Healthcare provider profile · identity verified

Laurie E Yntema, MD

Internal Medicine · BANGOR, ME · NPI 1508809500

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	483	60
Gabapentin	Gabapentin	415	76
Atorvastatin Calcium	Atorvastatin Calcium	346	87
Eliquis	Apixaban	328	54
Furosemide	Furosemide	279	59
Metoprolol Succinate	Metoprolol Succinate	238	46
Pantoprazole Sodium	Pantoprazole Sodium	234	52
Sertraline Hcl	Sertraline Hcl	233	59
Warfarin Sodium	Warfarin Sodium	225	14
Lisinopril	Lisinopril	198	42
Amlodipine Besylate	Amlodipine Besylate	181	43
Potassium Chloride	Potassium Chloride	179	44
Metoprolol Tartrate	Metoprolol Tartrate	138	28
Omeprazole	Omeprazole	126	30
Fluticasone Propionate	Fluticasone Propionate	110	30
Quetiapine Fumarate	Quetiapine Fumarate	109	24
Mirtazapine	Mirtazapine	106	28
Trazodone Hcl	Trazodone Hcl	105	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	104	24
Carvedilol	Carvedilol	100	22
Tamsulosin Hcl	Tamsulosin Hcl	100	26
Lamotrigine	Lamotrigine	96	11
Famotidine	Famotidine	94	24
Jardiance	Empagliflozin	80	16
Risperidone	Risperidone	80	20
Levetiracetam	Levetiracetam	79	15
Citalopram Hbr	Citalopram Hydrobromide	73	suppressed
Losartan Potassium	Losartan Potassium	73	25
Metformin Hcl	Metformin Hcl	73	21
Cephalexin	Cephalexin	70	32
Divalproex Sodium	Divalproex Sodium	70	11
Donepezil Hcl	Donepezil Hcl	69	suppressed
Tramadol Hcl	Tramadol Hcl	65	26
Buspirone Hcl	Buspirone Hcl	63	13
Baclofen	Baclofen	62	12
Allopurinol	Allopurinol	61	15
Carbidopa-Levodopa	Carbidopa/Levodopa	60	11
Incruse Ellipta	Umeclidinium Bromide	58	12
Hydralazine Hcl	Hydralazine Hcl	57	15
Latanoprost	Latanoprost	57	14
Prednisone	Prednisone	57	18
Clopidogrel	Clopidogrel Bisulfate	56	12
Venlafaxine Hcl Er	Venlafaxine Hcl	55	suppressed
Lorazepam	Lorazepam	52	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	17
Fluoxetine Hcl	Fluoxetine Hcl	48	suppressed
Bumetanide	Bumetanide	47	14
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	11
Xarelto	Rivaroxaban	43	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	14
Olanzapine	Olanzapine	41	12
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Bupropion Hcl Sr	Bupropion Hcl	39	suppressed
Clonazepam	Clonazepam	39	suppressed
Simvastatin	Simvastatin	38	suppressed
Sucralfate	Sucralfate	37	suppressed
Jantoven	Warfarin Sodium	36	suppressed
Torsemide	Torsemide	36	suppressed
Insulin Lispro	Insulin Lispro	35	12
Lactulose	Lactulose	35	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	33	11
Oxycodone Hcl	Oxycodone Hcl	33	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	18
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	30	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Metformin Hcl Er	Metformin Hcl	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	15
Cefuroxime	Cefuroxime Axetil	27	13
Copaxone	Glatiramer Acetate	27	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	27	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Montelukast Sodium	Montelukast Sodium	27	11
Nystatin	Nystatin	27	22
Glipizide	Glipizide	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Sulfasalazine	Sulfasalazine	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Finasteride	Finasteride	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	12
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	13
Myrbetriq	Mirabegron	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	13
Valproic Acid	Valproic Acid (As Sodium Salt)	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Diazepam	Diazepam	22	suppressed
Bupropion Hcl	Bupropion Hcl	21	suppressed
Ondansetron Odt	Ondansetron	21	13
Spironolactone	Spironolactone	21	suppressed
Atenolol	Atenolol	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	19	suppressed
Carbamazepine	Carbamazepine	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Fluconazole	Fluconazole	17	12
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Acetic Acid	Acetic Acid	16	suppressed
Primidone	Primidone	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Levofloxacin	Levofloxacin	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Metolazone	Metolazone	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Levocarnitine	Levocarnitine	13	suppressed
Ozempic	Semaglutide	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Roflumilast	Roflumilast	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Invokana	Canagliflozin	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Methimazole	Methimazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nayzilam	Midazolam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error